What we do

---

• Our breakthrough technology targets tRNA-modifying enzymes to create first-in-class small molecules—delivering multi-cancer therapies from a single drug, accelerating returns with scalable impact.
• By combining direct tumor destruction with immune activation through tRNA enzyme inhibition, THERAtRAME creates a new class of oncology drugs designed to overcome resistance and unlock treatments where current therapies fail.